SAN FRANCISCO--(BUSINESS WIRE)--Jaguar Animal Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, and high-value horses, announced today the appointment of Karen Wright as chief financial officer, effective immediately. John Kallassy, Jaguar’s former CFO, will continue to serve the Company as chief operating officer. Mr. Kallassy will assist with the transition of the CFO role.
